← Leaderboards
Christopher H Parsons
University Of Virginia Charlottesville
$5,433,160
Attributed
$5,433,160
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $819.2K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,433,160 · 9
By mechanism
R01$1,445,729 · 1
P20$1,287,367 · 4
R42$1,141,551 · 1
K08$715,043 · 1
R41$600,000 · 1
P60$243,470 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Dean H Kedes$13,137,487
- Jay C. Brown$3,172,093
- Edward H. Egelman$23,815,096
- Charles David Allis$30,045,613
- Timothy N Bullock$7,542,914
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCellsHuman Herpesvirus 8BaseFutureHerpesviridae InfectionsPathogenesisTumorInfectionHiv InfectionsKaposi SarcomaClinicPeripheral Blood Mononuclear CellLinkVirusToxic EffectResearch PersonnelResearch StudyIn VivoClinical ResearchAids/Hiv ProblemMortality Vital StatisticsEnvironmentExhibits
Grant awards (30)
HIV Clinical Tumor Biorepository (HTCB) Core$139,451
P20 · FY2021 · GM · contact PI
HIV Clinical Tumor Biorepository (HTCB) Core$139,462
P20 · FY2020 · GM · contact PI
HIV Clinical Tumor Biorepository (HTCB) Core$139,665
P20 · FY2019 · GM · contact PI
RC4: Alcohol & HIV-associated cancer pathogenesis$59,276
P60 · FY2019 · AA · contact PI
HIV Clinical Tumor Biorepository (HTCB) Core$139,498
P20 · FY2018 · GM · contact PI
RC4: Alcohol & HIV-associated cancer pathogenesis$45,903
P60 · FY2018 · AA · contact PI
HIV Clinical Tumor Biorepository (HTCB) Core$139,814
P20 · FY2017 · GM · contact PI
RC4: Alcohol & HIV-associated cancer pathogenesis$45,905
P60 · FY2017 · AA · contact PI
An Early-Phase Clinical Trial Evaluating ABC294640 in Patients with Refractory/Re$133,116
R42 · FY2016 · CA · contact PI
RC4: Alcohol & HIV-associated cancer pathogenesis$46,254
P60 · FY2016 · AA · contact PI
An Early-Phase Clinical Trial Evaluating ABC294640 in Patients with Refractory/Re$499,411
R42 · FY2015 · CA · contact PI
RC4: Alcohol & HIV-associated cancer pathogenesis$46,132
P60 · FY2015 · AA · contact PI
An Early-Phase Clinical Trial Evaluating ABC294640 in Patients with Refractory/Re$509,024
R42 · FY2014 · CA · contact PI
Regulation of the Tumor Microenvironment by KSHV$273,458
R01 · FY2014 · CA · contact PI
Regulation of the Tumor Microenvironment by KSHV$272,446
R01 · FY2013 · CA · contact PI
Regulation of the Tumor Microenvironment by KSHV$173,912
R01 · FY2012 · CA · contact PI
Regulation of the Tumor Microenvironment by KSHV$122,969
R01 · FY2012 · CA · contact PI
Lipid Metabolism and KSHV-associated Lymphoma Pathogenesis$300,000
R41 · FY2011 · AI · contact PI
Regulation of the Tumor Microenvironment by KSHV$296,881
R01 · FY2011 · CA · contact PI
KSHV REGULATION OF INNATE CYTOKINE RESPONSES AND T CELL ACTIVATION$211,010
P20 · FY2011 · RR · contact PI
Regulation of the Tumor Microenvironment by KSHV$306,063
R01 · FY2010 · CA · contact PI
Lipid Metabolism and KSHV-associated Lymphoma Pathogenesis$300,000
R41 · FY2010 · AI · contact PI
KSHV REGULATION OF INNATE CYTOKINE RESPONSES AND T CELL ACTIVATION$213,141
P20 · FY2010 · RR · contact PI
KSHV REGULATION OF INNATE CYTOKINE RESPONSES AND T CELL ACTIVATION$165,326
P20 · FY2009 · RR · contact PI
An Animal Model for Kaposi's Sarcoma$49,628
K08 · FY2009 · CA · contact PI
An Animal Model for Kaposi's Sarcoma$133,083
K08 · FY2008 · CA · contact PI
An Animal Model for Kaposi's Sarcoma$133,083
K08 · FY2007 · CA · contact PI
An Animal Model for Kaposi's Sarcoma$133,083
K08 · FY2006 · CA · contact PI
An Animal Model for Kaposi's Sarcoma$133,083
K08 · FY2005 · CA
An Animal Model for Kaposi's Sarcoma$133,083
K08 · FY2004 · CA